FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2780092364> ?p ?o ?g. }

• W2780092364 endingPage "S72" @default.
• W2780092364 startingPage "S65" @default.
• W2780092364 abstract "Naturally occurring botulism is rare, but a large number of cases could result from unintentional or intentional contamination of a commercial food. Despeciated, equine-derived, heptavalent botulinum antitoxin (HBAT) is licensed in the United States. Timely treatment reduces morbidity and mortality, but concerns that botulinum antitoxin can induce anaphylaxis exist. We sought to quantify the allergy risk of botulinum antitoxin treatment and the usefulness of skin testing to assess this risk. We conducted a systematic review of (1) allergic reactions to botulinum antitoxin and (2) the predictive value of skin testing (ST) before botulinum antitoxin administration. We searched 5 scientific literature databases, reviewed articles’ references, and obtained data from the HBAT manufacturer and from the Centers for Disease Control and Prevention. Anaphylaxis incidence was determined for HBAT and previously employed botulinum antitoxins. We calculated the positive predictive value (PPV) and negative predictive value (NPV) of ST for anaphylaxis related to HBAT and other botulinum antitoxins. Seven articles were included. Anaphylaxis incidence was 1.64% (5/305 patients) for HBAT and 1.16% (8/687 patients) for all other botulinum antitoxins (relative risk, 1.41 [95% confidence interval, .47–4.27]; P = .5). Observed values for both PPV and NPV for HBAT-ST (33 patients) were 100%. Observed PPVs and NPVs of ST for other botulinum antitoxins (302 patients) were 0–56% and 50%–100%, respectively. There were no reports of fatal anaphylaxis. Considering the <2 % rate of anaphylaxis, fatal outcomes, modest predictive value of ST, resource requirements for ST, and the benefits of early treatment, data do not support delaying HBAT administration to perform ST in a mass botulinum toxin exposure. Anaphylactic reactions may occur among 1%–2% of botulinum antitoxin recipients and will require epinephrine and antihistamine treatment and, possibly, intensive care." @default.
• W2780092364 created "2018-01-05" @default.
• W2780092364 creator A5022037639 @default.
• W2780092364 creator A5028607202 @default.
• W2780092364 creator A5028761825 @default.
• W2780092364 creator A5034247286 @default.
• W2780092364 creator A5052548559 @default.
• W2780092364 creator A5055783272 @default.
• W2780092364 creator A5088167129 @default.
• W2780092364 date "2017-12-27" @default.
• W2780092364 modified "2023-10-17" @default.
• W2780092364 title "Workgroup Report by the Joint Task Force Involving American Academy of Allergy, Asthma & Immunology (AAAAI); Food Allergy, Anaphylaxis, Dermatology and Drug Allergy (FADDA) (Adverse Reactions to Foods Committee and Adverse Reactions to Drugs, Biologicals, and Latex Committee); and the Centers for Disease Control and Prevention Botulism Clinical Treatment Guidelines Workgroup—Allergic Reactions to Botulinum Antitoxin: A Systematic Review" @default.
• W2780092364 cites W11539491 @default.
• W2780092364 cites W118858215 @default.
• W2780092364 cites W1441666804 @default.
• W2780092364 cites W1981764249 @default.
• W2780092364 cites W1986944082 @default.
• W2780092364 cites W1992484278 @default.
• W2780092364 cites W1993964853 @default.
• W2780092364 cites W2005593824 @default.
• W2780092364 cites W2038877991 @default.
• W2780092364 cites W2040640289 @default.
• W2780092364 cites W2041884522 @default.
• W2780092364 cites W2052951012 @default.
• W2780092364 cites W2081516224 @default.
• W2780092364 cites W2081769761 @default.
• W2780092364 cites W2089836311 @default.
• W2780092364 cites W2116640220 @default.
• W2780092364 cites W2119984695 @default.
• W2780092364 cites W2122164264 @default.
• W2780092364 cites W2126213235 @default.
• W2780092364 cites W2127003103 @default.
• W2780092364 cites W2137889830 @default.
• W2780092364 cites W2156098321 @default.
• W2780092364 cites W2169368165 @default.
• W2780092364 cites W2203696952 @default.
• W2780092364 cites W2225433666 @default.
• W2780092364 cites W2334755871 @default.
• W2780092364 cites W2412254665 @default.
• W2780092364 cites W2468996569 @default.
• W2780092364 cites W2578933961 @default.
• W2780092364 cites W2740139987 @default.
• W2780092364 cites W4206160836 @default.
• W2780092364 cites W4231467619 @default.
• W2780092364 cites W4252071217 @default.
• W2780092364 doi "https://doi.org/10.1093/cid/cix827" @default.
• W2780092364 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/5850017" @default.
• W2780092364 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/29293931" @default.
• W2780092364 hasPublicationYear "2017" @default.
• W2780092364 type Work @default.
• W2780092364 sameAs 2780092364 @default.
• W2780092364 citedByCount "21" @default.
• W2780092364 countsByYear W27800923642017 @default.
• W2780092364 countsByYear W27800923642018 @default.
• W2780092364 countsByYear W27800923642019 @default.
• W2780092364 countsByYear W27800923642020 @default.
• W2780092364 countsByYear W27800923642021 @default.
• W2780092364 countsByYear W27800923642022 @default.
• W2780092364 countsByYear W27800923642023 @default.
• W2780092364 crossrefType "journal-article" @default.
• W2780092364 hasAuthorship W2780092364A5022037639 @default.
• W2780092364 hasAuthorship W2780092364A5028607202 @default.
• W2780092364 hasAuthorship W2780092364A5028761825 @default.
• W2780092364 hasAuthorship W2780092364A5034247286 @default.
• W2780092364 hasAuthorship W2780092364A5052548559 @default.
• W2780092364 hasAuthorship W2780092364A5055783272 @default.
• W2780092364 hasAuthorship W2780092364A5088167129 @default.
• W2780092364 hasBestOaLocation W27800923641 @default.
• W2780092364 hasConcept C120665830 @default.
• W2780092364 hasConcept C121332964 @default.
• W2780092364 hasConcept C126322002 @default.
• W2780092364 hasConcept C141071460 @default.
• W2780092364 hasConcept C16005928 @default.
• W2780092364 hasConcept C185592680 @default.
• W2780092364 hasConcept C203014093 @default.
• W2780092364 hasConcept C207480886 @default.
• W2780092364 hasConcept C2775933838 @default.
• W2780092364 hasConcept C2776042228 @default.
• W2780092364 hasConcept C2777367657 @default.
• W2780092364 hasConcept C2777478456 @default.
• W2780092364 hasConcept C2778973234 @default.
• W2780092364 hasConcept C55493867 @default.
• W2780092364 hasConcept C61511704 @default.
• W2780092364 hasConcept C71924100 @default.
• W2780092364 hasConceptScore W2780092364C120665830 @default.
• W2780092364 hasConceptScore W2780092364C121332964 @default.
• W2780092364 hasConceptScore W2780092364C126322002 @default.
• W2780092364 hasConceptScore W2780092364C141071460 @default.
• W2780092364 hasConceptScore W2780092364C16005928 @default.
• W2780092364 hasConceptScore W2780092364C185592680 @default.
• W2780092364 hasConceptScore W2780092364C203014093 @default.
• W2780092364 hasConceptScore W2780092364C207480886 @default.
• W2780092364 hasConceptScore W2780092364C2775933838 @default.
• W2780092364 hasConceptScore W2780092364C2776042228 @default.
• W2780092364 hasConceptScore W2780092364C2777367657 @default.
• W2780092364 hasConceptScore W2780092364C2777478456 @default.
• W2780092364 hasConceptScore W2780092364C2778973234 @default.
• W2780092364 hasConceptScore W2780092364C55493867 @default.

• next